This report aims to provide a comprehensive presentation of the global market for Genomic Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Cancer Testing. This report contains market size and forecasts of Genomic Cancer Testing in global, including the following market information:
Global Genomic Cancer Testing Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Genomic Cancer Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Fluorescence In Situ Hybridization Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Genomic Cancer Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Genomic Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genomic Cancer Testing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Genomic Cancer Testing Market Segment Percentages, by Type, 2022 (%)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Global Genomic Cancer Testing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Genomic Cancer Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Global Genomic Cancer Testing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Genomic Cancer Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genomic Cancer Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Genomic Cancer Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genomic Cancer Testing, market overview.
Chapter 2: Global Genomic Cancer Testing market size in revenue.
Chapter 3: Detailed analysis of Genomic Cancer Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genomic Cancer Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genomic Cancer Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genomic Cancer Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genomic Cancer Testing Overall Market Size
2.1 Global Genomic Cancer Testing Market Size: 2022 VS 2032
2.2 Global Genomic Cancer Testing Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genomic Cancer Testing Players in Global Market
3.2 Top Global Genomic Cancer Testing Companies Ranked by Revenue
3.3 Global Genomic Cancer Testing Revenue by Companies
3.4 Top 3 and Top 5 Genomic Cancer Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genomic Cancer Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genomic Cancer Testing Players in Global Market
3.6.1 List of Global Tier 1 Genomic Cancer Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Genomic Cancer Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genomic Cancer Testing Market Size Markets, 2022 & 2032
4.1.2 Fluorescence In Situ Hybridization
4.1.3 Polymerase Chain Reaction
4.1.4 Microarray Technology
4.1.5 Serum Proteomics
4.1.6 Nucleic Acid Sequencing
4.2 By Type - Global Genomic Cancer Testing Revenue & Forecasts
4.2.1 By Type - Global Genomic Cancer Testing Revenue, 2018-2023
4.2.2 By Type - Global Genomic Cancer Testing Revenue, 2024-2032
4.2.3 By Type - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genomic Cancer Testing Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Speciality Clinics
5.1.4 Research Institutes
5.1.5 Diagnostics Laboratories
5.1.6 Biopharmaceutical Companies
5.2 By Application - Global Genomic Cancer Testing Revenue & Forecasts
5.2.1 By Application - Global Genomic Cancer Testing Revenue, 2018-2023
5.2.2 By Application - Global Genomic Cancer Testing Revenue, 2024-2032
5.2.3 By Application - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Genomic Cancer Testing Market Size, 2022 & 2032
6.2 By Region - Global Genomic Cancer Testing Revenue & Forecasts
6.2.1 By Region - Global Genomic Cancer Testing Revenue, 2018-2023
6.2.2 By Region - Global Genomic Cancer Testing Revenue, 2024-2032
6.2.3 By Region - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Genomic Cancer Testing Revenue, 2018-2032
6.3.2 US Genomic Cancer Testing Market Size, 2018-2032
6.3.3 Canada Genomic Cancer Testing Market Size, 2018-2032
6.3.4 Mexico Genomic Cancer Testing Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Genomic Cancer Testing Revenue, 2018-2032
6.4.2 Germany Genomic Cancer Testing Market Size, 2018-2032
6.4.3 France Genomic Cancer Testing Market Size, 2018-2032
6.4.4 U.K. Genomic Cancer Testing Market Size, 2018-2032
6.4.5 Italy Genomic Cancer Testing Market Size, 2018-2032
6.4.6 Russia Genomic Cancer Testing Market Size, 2018-2032
6.4.7 Nordic Countries Genomic Cancer Testing Market Size, 2018-2032
6.4.8 Benelux Genomic Cancer Testing Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Genomic Cancer Testing Revenue, 2018-2032
6.5.2 China Genomic Cancer Testing Market Size, 2018-2032
6.5.3 Japan Genomic Cancer Testing Market Size, 2018-2032
6.5.4 South Korea Genomic Cancer Testing Market Size, 2018-2032
6.5.5 Southeast Asia Genomic Cancer Testing Market Size, 2018-2032
6.5.6 India Genomic Cancer Testing Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Genomic Cancer Testing Revenue, 2018-2032
6.6.2 Brazil Genomic Cancer Testing Market Size, 2018-2032
6.6.3 Argentina Genomic Cancer Testing Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genomic Cancer Testing Revenue, 2018-2032
6.7.2 Turkey Genomic Cancer Testing Market Size, 2018-2032
6.7.3 Israel Genomic Cancer Testing Market Size, 2018-2032
6.7.4 Saudi Arabia Genomic Cancer Testing Market Size, 2018-2032
6.7.5 UAE Genomic Cancer Testing Market Size, 2018-2032
7 Genomic Cancer Testing Companies Profiles
7.1 Devyser
7.1.1 Devyser Company Summary
7.1.2 Devyser Business Overview
7.1.3 Devyser Genomic Cancer Testing Major Product Offerings
7.1.4 Devyser Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.1.5 Devyser Key News & Latest Developments
7.2 Agendia
7.2.1 Agendia Company Summary
7.2.2 Agendia Business Overview
7.2.3 Agendia Genomic Cancer Testing Major Product Offerings
7.2.4 Agendia Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.2.5 Agendia Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Genomic Cancer Testing Major Product Offerings
7.3.4 Illumina Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.3.5 Illumina Key News & Latest Developments
7.4 Personal Genome Diagnostics
7.4.1 Personal Genome Diagnostics Company Summary
7.4.2 Personal Genome Diagnostics Business Overview
7.4.3 Personal Genome Diagnostics Genomic Cancer Testing Major Product Offerings
7.4.4 Personal Genome Diagnostics Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.4.5 Personal Genome Diagnostics Key News & Latest Developments
7.5 Veracyte
7.5.1 Veracyte Company Summary
7.5.2 Veracyte Business Overview
7.5.3 Veracyte Genomic Cancer Testing Major Product Offerings
7.5.4 Veracyte Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.5.5 Veracyte Key News & Latest Developments
7.6 Pacific Biosciences of California
7.6.1 Pacific Biosciences of California Company Summary
7.6.2 Pacific Biosciences of California Business Overview
7.6.3 Pacific Biosciences of California Genomic Cancer Testing Major Product Offerings
7.6.4 Pacific Biosciences of California Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.6.5 Pacific Biosciences of California Key News & Latest Developments
7.7 Qiagen
7.7.1 Qiagen Company Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Genomic Cancer Testing Major Product Offerings
7.7.4 Qiagen Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.7.5 Qiagen Key News & Latest Developments
7.8 Agilent Technologies
7.8.1 Agilent Technologies Company Summary
7.8.2 Agilent Technologies Business Overview
7.8.3 Agilent Technologies Genomic Cancer Testing Major Product Offerings
7.8.4 Agilent Technologies Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.8.5 Agilent Technologies Key News & Latest Developments
7.9 Natera
7.9.1 Natera Company Summary
7.9.2 Natera Business Overview
7.9.3 Natera Genomic Cancer Testing Major Product Offerings
7.9.4 Natera Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.9.5 Natera Key News & Latest Developments
7.10 Bio Rad Laboratories
7.10.1 Bio Rad Laboratories Company Summary
7.10.2 Bio Rad Laboratories Business Overview
7.10.3 Bio Rad Laboratories Genomic Cancer Testing Major Product Offerings
7.10.4 Bio Rad Laboratories Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.10.5 Bio Rad Laboratories Key News & Latest Developments
7.11 Myriad Genetics
7.11.1 Myriad Genetics Company Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Genomic Cancer Testing Major Product Offerings
7.11.4 Myriad Genetics Genomic Cancer Testing Revenue in Global Market (2018-2023)
7.11.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genomic Cancer Testing Market Opportunities & Trends in Global Market
Table 2. Genomic Cancer Testing Market Drivers in Global Market
Table 3. Genomic Cancer Testing Market Restraints in Global Market
Table 4. Key Players of Genomic Cancer Testing in Global Market
Table 5. Top Genomic Cancer Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Genomic Cancer Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Genomic Cancer Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Genomic Cancer Testing Product Type
Table 9. List of Global Tier 1 Genomic Cancer Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genomic Cancer Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Genomic Cancer Testing Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Genomic Cancer Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Genomic Cancer Testing Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Genomic Cancer Testing Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Genomic Cancer Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Genomic Cancer Testing Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Genomic Cancer Testing Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Genomic Cancer Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Genomic Cancer Testing Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Genomic Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Genomic Cancer Testing Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Genomic Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Genomic Cancer Testing Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Genomic Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Genomic Cancer Testing Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Genomic Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Genomic Cancer Testing Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Genomic Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Genomic Cancer Testing Revenue, (US$, Mn), 2024-2032
Table 30. Devyser Company Summary
Table 31. Devyser Genomic Cancer Testing Product Offerings
Table 32. Devyser Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Devyser Key News & Latest Developments
Table 34. Agendia Company Summary
Table 35. Agendia Genomic Cancer Testing Product Offerings
Table 36. Agendia Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Agendia Key News & Latest Developments
Table 38. Illumina Company Summary
Table 39. Illumina Genomic Cancer Testing Product Offerings
Table 40. Illumina Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Illumina Key News & Latest Developments
Table 42. Personal Genome Diagnostics Company Summary
Table 43. Personal Genome Diagnostics Genomic Cancer Testing Product Offerings
Table 44. Personal Genome Diagnostics Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Personal Genome Diagnostics Key News & Latest Developments
Table 46. Veracyte Company Summary
Table 47. Veracyte Genomic Cancer Testing Product Offerings
Table 48. Veracyte Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Veracyte Key News & Latest Developments
Table 50. Pacific Biosciences of California Company Summary
Table 51. Pacific Biosciences of California Genomic Cancer Testing Product Offerings
Table 52. Pacific Biosciences of California Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Pacific Biosciences of California Key News & Latest Developments
Table 54. Qiagen Company Summary
Table 55. Qiagen Genomic Cancer Testing Product Offerings
Table 56. Qiagen Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Qiagen Key News & Latest Developments
Table 58. Agilent Technologies Company Summary
Table 59. Agilent Technologies Genomic Cancer Testing Product Offerings
Table 60. Agilent Technologies Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Agilent Technologies Key News & Latest Developments
Table 62. Natera Company Summary
Table 63. Natera Genomic Cancer Testing Product Offerings
Table 64. Natera Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Natera Key News & Latest Developments
Table 66. Bio Rad Laboratories Company Summary
Table 67. Bio Rad Laboratories Genomic Cancer Testing Product Offerings
Table 68. Bio Rad Laboratories Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Bio Rad Laboratories Key News & Latest Developments
Table 70. Myriad Genetics Company Summary
Table 71. Myriad Genetics Genomic Cancer Testing Product Offerings
Table 72. Myriad Genetics Genomic Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 73. Myriad Genetics Key News & Latest Developments
List of Figures
Figure 1. Genomic Cancer Testing Segment by Type in 2022
Figure 2. Genomic Cancer Testing Segment by Application in 2022
Figure 3. Global Genomic Cancer Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genomic Cancer Testing Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Genomic Cancer Testing Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genomic Cancer Testing Revenue in 2022
Figure 8. By Type - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 9. By Application - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 10. By Type - Global Genomic Cancer Testing Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 12. By Application - Global Genomic Cancer Testing Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 14. By Region - Global Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 15. By Country - North America Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 16. US Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 20. Germany Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 21. France Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 28. China Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 32. India Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 34. Brazil Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Genomic Cancer Testing Revenue Market Share, 2018-2032
Figure 37. Turkey Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Genomic Cancer Testing Revenue, (US$, Mn), 2018-2032
Figure 41. Devyser Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Agendia Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Illumina Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Personal Genome Diagnostics Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Veracyte Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pacific Biosciences of California Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Qiagen Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Agilent Technologies Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Natera Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bio Rad Laboratories Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Myriad Genetics Genomic Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
